$OKLO

Cochran Caroline sold $1.7M of OKLO

Cochran Caroline (Co-Founder, COO) sold 40,000 shares of Oklo Inc. (OKLO) at $41.35 ($1.65M total) on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cochran Caroline
Published Aug 5, 2026, 8:06 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OKLO
Neutral
high confidence
Mentioned
$OKLO
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OKLONeutralLow
01

Why it matters

This disclosure updates the record of insider activity but does not introduce new guidance, contracts, regulatory actions, or operational changes.

02

Market read

Traders may note the insider sale for sentiment monitoring, but there is no fundamental catalyst in the text.

03

What to watch

The filing does not state the insider’s tax or liquidity needs, and 10b5-1 sales can be mechanically scheduled regardless of near-term outlook.

Relevance 5/10Novelty 3/10Timing: filed Aug 5, transaction dated Aug 3 (after-hours disclosure window)

Background

The article is an SEC Form 4 insider transaction for Oklo Inc., reported by a co-founder/COO who is also a director and 10% owner.

Company-level read

Ticker impact

$OKLONeutralHigh confidence
Context

Oklo co-founder and COO Cochran Caroline sold 40,000 shares at $41.35 on an open-market sale under a 10b5-1 plan, per Form 4.

Expected impact

Limited near-term impact; any effect is likely sentiment-only and outweighed by the 10b5-1 context.

Evidence & confidence

Form 4 insider sales under a pre-arranged 10b5-1 plan are typically interpreted as liquidity/plan execution rather than a fresh negative signal, and the article provides no new company fundamentals.

Market effects

No clear sector read-through from a single 10b5-1 insider sale disclosure.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still be read as reduced conviction, especially if paired with other negative signals not present here.

Key entities

  • Oklo Inc.

    Subject of the Form 4 insider sale disclosure.

  • Cochran Caroline

    Oklo co-founder, COO, director, and 10% owner who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HNUCMed

A New Nuclear Rival Recently Filed to Go Public. Should Oklo Investors Be Worried?

Holtec Nuclear Corporation filed for an IPO on Nasdaq (ticker HNUC), generating $165M revenue and $17.8M net income in Q1 2024. Unlike Oklo (OKLO), Holtec has existing revenue and earnings, focusing on nuclear equipment, waste management, and SMR development. Holtec plans to use IPO proceeds for SMR programs and expansion. Oklo, a pre-commercial nuclear startup, has minimal revenue and significant losses, raising concerns for investors.

$CCJMedAI 8/10

AI Energy Demands Surge, Nuclear Power Seeks to Break the Deadlock

Nuclear energy sector is poised for long-term growth due to rising AI data center demand and government policies. Cameco (CCJ) benefits from uranium mining and reactor manufacturing. GE Vernova (GEV) is developing small modular reactors with a project scheduled for 2029. High-risk startups Oklo (OKLO) and NuScale Power (SMR) are seeking commercial agreements for future deployment.

MedAI 8/10

Oklo aims to turn nuclear waste into clean energy

Oklo Inc. plans to invest $1.68B to build a nuclear fuel recycling facility in Oak Ridge, converting used nuclear fuel into reusable materials. The company aims to address rising electricity demand and domestic HALEU supply shortages. Christina Leggett, director of fuel cycle technology, leads the project, leveraging pyroprocessing technology.

$OKLOMed

Oklo Climbs 12% As Supply Concerns Spark Rally In Advanced Nuclear Stocks

Oklo (OKLO) stock rose 12% to $44 on supply concerns amid U.S.-Canada trade tensions, adding $850M to its market cap. The company's Aurora reactors rely on advanced fuels, and recent political developments highlight risks tied to material access. Oklo has strong cash reserves ($3.01B) and operational milestones, like its Groves reactor reaching criticality. Analysts' price targets range from $14 to $130, with an average of $80.